Build: http://jenkins.thetaphi.de/job/Lucene-Solr-trunk-MacOSX/1448/
Java: 64bit/jdk1.8.0 -XX:-UseCompressedOops -XX:+UseParallelGC

All tests passed

Build Log:
[...truncated 31719 lines...]
-check-forbidden-all:
[forbidden-apis] Reading bundled API signatures: jdk-unsafe-1.7
[forbidden-apis] Reading bundled API signatures: jdk-deprecated-1.7
[forbidden-apis] Reading bundled API signatures: commons-io-unsafe-2.1
[forbidden-apis] Reading API signatures: 
/Users/jenkins/workspace/Lucene-Solr-trunk-MacOSX/lucene/tools/forbiddenApis/base.txt
[forbidden-apis] Reading API signatures: 
/Users/jenkins/workspace/Lucene-Solr-trunk-MacOSX/lucene/tools/forbiddenApis/servlet-api.txt
[forbidden-apis] Loading classes to check...
[forbidden-apis] Scanning for API signatures and dependencies...
[forbidden-apis] Forbidden method invocation: 
java.lang.String#format(java.lang.String,java.lang.Object[]) [Uses default 
locale]
[forbidden-apis]   in org.apache.solr.CursorPagingTest 
(CursorPagingTest.java:969)
[forbidden-apis] Scanned 2139 (and 1380 related) class file(s) for forbidden 
API invocations (in 3.90s), 1 error(s).

BUILD FAILED
/Users/jenkins/workspace/Lucene-Solr-trunk-MacOSX/build.xml:467: The following 
error occurred while executing this line:
/Users/jenkins/workspace/Lucene-Solr-trunk-MacOSX/build.xml:70: The following 
error occurred while executing this line:
/Users/jenkins/workspace/Lucene-Solr-trunk-MacOSX/solr/build.xml:271: The 
following error occurred while executing this line:
/Users/jenkins/workspace/Lucene-Solr-trunk-MacOSX/solr/common-build.xml:479: 
Check for forbidden API calls failed, see log.

Total time: 110 minutes 8 seconds
Build step 'Invoke Ant' marked build as failure
Description set: Java: 64bit/jdk1.8.0 -XX:-UseCompressedOops -XX:+UseParallelGC
Archiving artifacts
Recording test results
Email was triggered for: Failure
Sending email for trigger: Failure


---------------------------------------------------------------------
To unsubscribe, e-mail: [email protected]
For additional commands, e-mail: [email protected]

Reply via email to